Gene correction for a rare disease

Gene correction for a rare disease

Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.

Until now there has been no effective treatment, but a new gene therapy developed within the EU-funded project AIPgene could provide patients an end to their ordeal and reactivate the production of the missing protein. The new gene therapy consists of a single injection of a viral vector containing the healthy gene. Such gene will then replace the mutated one in . This treatment is expected to stop the symptoms of the disease for five to ten years, depending on the life cycle of the cells in the liver.

During the phase I of a clinical trial Angeles and seven other patients have received this treatment, and so far AIP attacks have been reduced significantly among this group. In addition, there are no side effects visible. These promising results indicate that within a few years, the new therapy could be available to all patients.

This video is not supported by your browser at this time.


Related Stories

Predicting hepatitis C treatment success

date May 08, 2014

Levels of interferon-stimulated genes in the liver and blood could help predict if a patient with hepatitis C will respond to conventional therapy, researchers at Kanazawa University suggest.

Targeted gene therapy enhances treatment for Pompe disease

date Jun 25, 2012

Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of throughout the body,suppresses ...

Recommended for you

Team discovers key step in how taste buds regenerate

date May 28, 2015

Researchers at the University of Colorado Anschutz Medical Campus have discovered a key molecular pathway that aids in the renewal of taste buds, a finding that may help cancer patients suffering from an ...

How mutations in a high risk gene affect motor neurons

date May 28, 2015

Scientists at the flagship motor neuron disease research centre, based at the University of Sheffield, investigated how specialised nerve cells that control voluntary movements die – something which is ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.